BETA
Sports medicine company developing knotless, retensionable soft-tissue repair and fixation systems, with an initial focus on meniscal root and ACL procedures.
Native Orthopaedics is a privately held sports medicine company based in Providence, Rhode Island. Founded by orthopaedic surgeon Christian Anderson and Tom Gamache, it develops implants and instruments intended to preserve native anatomy during joint repair. The company lists 2024 as its founding year, following earlier development work.
Its Native Root System combines Dragonfly retensionable suture constructs with titanium or Zerofly textile fixation and procedure-specific instruments. The broader ACL platform includes Prime Zero, tibial eminence repair options and ACL Prime, which the current website labels coming soon.
The regulatory records linked to these systems name Riverpoint Medical as the FDA applicant and use the device names RootMend MRR, LigaMend and Strut Suture / No-Tie Button. Native has announced the related clearances under its commercial branding. These are 510(k) clearances for specified fixation uses, not FDA approval of broader claims about arthritis prevention or superior clinical outcomes.
Native’s Root/RootMend and Repair Construct/Native Bridge platform records are linked to specified Riverpoint Medical authorizations. The original applicant is retained. Other Riverpoint anchors, sutures and Covidien-branded recalls are not automatically Native products and are excluded. Configuration-level mapping and U.S. commercial launch of the ACL platform are not established by the current disclosures. [13][15][4][3][22][23][1]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [8][6]
Latest recorded source review: 2026-10-20.
Scope: selected product families.
Documented commercial product families.
Meniscal root repair family combining Dragonfly retensionable suture constructs, optional titanium No-Tie or Zerofly soft fixation, and RootFinder and Spear Passer instruments. The FDA record uses the earlier RootMend MRR name. [23][13][11]
FDA-clearedCommercially available; ordering and configuration availability through Native.
Related soft-tissue repair and fixation constructs for ACL/PCL procedures. The website presents Prime Zero and tibial eminence options as new, while ACL Prime is marked coming soon. Native Bridge distributes suture tension; configurations should be checked individually. [19][20][15][14][11]
Commercial availability not establishedManufacturer presents new configurations and technique guides; ACL Prime is marked coming soon. Individual shipping status requires confirmation.
Publicly documented relationships; coverage may be incomplete.
| Partner | Territory / scope | Products |
|---|---|---|
| Kaizen Medical [10] | Tennessee & Kentucky (service area) | Not publicly specified |
Sources checked October 16, 2026.
FDA cleared Strut Suture / No-Tie Button for specified fixation uses. Native described the related Native Bridge clearance in its March announcement. [14][20]
FDA cleared LigaMend for specified shoulder, foot/ankle and knee repair uses. Native subsequently announced the related Repair Construct expansion. [4][15][20]
Native reports receiving the Accelerating the Cutting Edge Award at the July 11 AOSSM meeting. Its announcement was published July 22. [21]
Accessed 10/20/2026